Taiho Ventures

Portfolio Co Investors 2026 for Taiho Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Taiho Ventures accounts for 10 tracked companies with verified cap-table data, 10 of which disclose round sizes totalling $633M. The median disclosed raise is $62M, and the largest is Storm Therapeutics at $126M, ahead of Orna Therapeutics ($100M) and Normunity ($65M).

The names that recur most often on these co-invested cap tables are Taiho Ventures (10 companies), MPM Capital (3 companies), M Ventures (2 companies), Pfizer Ventures (2 companies), Bristol Myers Squibb (2 companies), Northpond Ventures (2 companies). By latest disclosed round, the market skews Series A (8), Series C (1), Series B (1).

Best funded Taiho Ventures companies

  1. Storm Therapeutics — $126M (latest: Series C)
  2. Orna Therapeutics — $100M (latest: Series A)
  3. Normunity — $65M (latest: Series A)
  4. Parthenon Therapeutics — $65M (latest: Series A)
  5. Light Horse Therapeutics — $62M (latest: Series A)
  6. Werewolf Therapeutics — $56M (latest: Series A)
  7. Transition Bio — $50M (latest: Series A)
  8. Harpoon Therapeutics — $45M (latest: Series B)
  9. hC Bioscience — $40M (latest: Series A)
  10. Theolytics — $25M (latest: Series A)

Taiho Ventures — related firms and companies (53)

Taiho Ventures alternatives · All research reports